<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39457522</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Bacterial and Viral Co-Infections in COVID-19 Patients: Etiology and Clinical Impact.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2210</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12102210</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mixed infections can worsen disease symptoms. This study investigated the impact of mixed infections with viral and bacterial pathogens in patients positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using the in-house multiplex PCR method, we tested 337 SARS-CoV-2 positive samples for co-infections with three bacterial and 14 other viral pathogens.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between August 2021 and May 2022, 8% of 337 SARS-CoV-2-positive patients had bacterial co-infections, 5.6% had viral co-infections, and 1.4% had triple mixed infections. The most common causes of mixed infections were <i>Haemophilus influenzae</i> (5.93%) and respiratory syncytial virus (RSV) (1.18%). Children &lt; 5 years old had more frequent co-infections than adults &lt; 65 years old (20.8% vs. 16.4%), while adults showed a more severe clinical picture with a higher C-reactive protein (CRP) level (78.1 vs.16.2 mg/L; <i>p</i> = 0.033), a lower oxygen saturation (SpO2) (89.5 vs. 93.2%), and a longer hospital stay (8.1 vs. 3.1 days; <i>p</i> = 0.025) (mean levels). The risk of a fatal outcome was 41% in unvaccinated patients (<i>p</i> = 0.713), which increased by 2.66% with co-infection with two pathogens (<i>p</i> = 0.342) and by 26% with three pathogens (<i>p</i> = 0.005). Additionally, 50% of intensive care unit (ICU) patients had a triple infection, compared with only 1.3% in the inpatient unit (<i>p</i> = 0.0029). The risk of death and/or ICU admission was 12 times higher (<i>p</i> = 0.042) with an additional pathogen and increased by 95% (<i>p</i> = 0.003) with a third concomitant pathogen.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Regular multiplex testing is important for prompt treatment and targeted antibiotic use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trifonova</LastName><ForeName>Ivelina</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4543-6831</Identifier><AffiliationInfo><Affiliation>National Laboratory "Influenza and ARD", Department of Virology, National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madzharova</LastName><ForeName>Iveta</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-1965-7550</Identifier><AffiliationInfo><Affiliation>National Laboratory "Influenza and ARD", Department of Virology, National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korsun</LastName><ForeName>Neli</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3188-2283</Identifier><AffiliationInfo><Affiliation>National Laboratory "Influenza and ARD", Department of Virology, National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levterova</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Laboratory "Influenza and ARD", Department of Virology, National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velikov</LastName><ForeName>Petar</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7436-4064</Identifier><AffiliationInfo><Affiliation>Infectious Disease Hospital "Prof. Ivan Kirov", Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voleva</LastName><ForeName>Silvya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Disease Hospital "Prof. Ivan Kirov", Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanov</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3320-5697</Identifier><AffiliationInfo><Affiliation>Infectious Disease Hospital "Prof. Ivan Kirov", Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanov</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0001-7360-4302</Identifier><AffiliationInfo><Affiliation>Infectious Disease Hospital "Prof. Ivan Kirov", Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yordanova</LastName><ForeName>Ralitsa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0009-8456-8851</Identifier><AffiliationInfo><Affiliation>Infectious Disease Hospital "Prof. Ivan Kirov", Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tcherveniakova</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Infectious Disease Hospital "Prof. Ivan Kirov", Department for Infectious Diseases, Parasitology and Tropical Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelova</LastName><ForeName>Svetla</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Virology Laboratory, University Hospital "Prof. Dr. Stoyan Kirkovich", Trakia University, 6000 Stara Zagora, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christova</LastName><ForeName>Iva</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>National Laboratory "Influenza and ARD", Department of Virology, National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Haemophilus influenzae</Keyword><Keyword MajorTopicYN="N">RSV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">co-infection</Keyword><Keyword MajorTopicYN="N">respiratory viruses</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457522</ArticleId><ArticleId IdType="pmc">PMC11505336</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12102210</ArticleId><ArticleId IdType="pii">biomedicines12102210</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Principi N., Autore G., Ramundo G., Esposito S. Epidemiology of respiratory infections during the COVID-19 pandemic. Viruses. 2023;15:1160. doi: 10.3390/v15051160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051160</ArticleId><ArticleId IdType="pmc">PMC10224029</ArticleId><ArticleId IdType="pubmed">37243246</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene S.K., Levin-Rector A., Kyaw N.T., Luoma E., Amin H., McGibbon E., Mathes R.W., Ahuja S.D. Comparative hospitalization risk for SARS-CoV-2 Omicron and Delta variant infections, by variant predominance periods and patient-level sequencing results, New York City, August 2021–January 2022. Influenza Other Respir. Viruses. 2023;17:e13062. doi: 10.1111/irv.13062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13062</ArticleId><ArticleId IdType="pmc">PMC9835408</ArticleId><ArticleId IdType="pubmed">36317297</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen S.J., Azziz-Baumgartner E., Budd A.P., Brammer L., Sullivan S., Pineda R.F., Cohen C., Fry A.M. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa. Am. J. Transplant. 2020;20:3681–3685. doi: 10.1111/ajt.16381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16381</ArticleId><ArticleId IdType="pmc">PMC7753605</ArticleId><ArticleId IdType="pubmed">33264506</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves H.E., Papenburg J., Mehta K., Bettinger J.A., Sadarangani M., Halperin S.A., Morris S.K., Lefebvre M.A. The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based study. Lancet Reg. Health-Am. 2022;7:100132. doi: 10.1016/j.lana.2021.100132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100132</ArticleId><ArticleId IdType="pmc">PMC8913102</ArticleId><ArticleId IdType="pubmed">35291567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Wang Y., Shen C., Luo J., Yu W. Decreased Incidence of Influenza During the COVID-19 Pandemic. Int. J. Gen. Med. 2022;15:2957. doi: 10.2147/IJGM.S343940.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S343940</ArticleId><ArticleId IdType="pmc">PMC8932933</ArticleId><ArticleId IdType="pubmed">35308571</ArticleId></ArticleIdList></Reference><Reference><Citation>Avolio M., Venturini S., De Rosa R., Crapis M., Basaglia G. Epidemiology of respiratory virus before and during COVID-19 pandemic. Le Infez. Med. 2022;30:104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8929737</ArticleId><ArticleId IdType="pubmed">35350252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelia Y., Procop G.W., Richter S.S., Worley S., Liu W., Esper F. Dynamics and predisposition of respiratory viral co-infections in children and adults. Clin. Microbiol. Infect. 2021;27:631.e1–631.e6. doi: 10.1016/j.cmi.2020.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.05.042</ArticleId><ArticleId IdType="pubmed">32540470</ArticleId></ArticleIdList></Reference><Reference><Citation>Peci A., Tran V., Guthrie J.L., Li Y., Nelson P., Schwartz K.L., Eshaghi A., Buchan S.A., Gubbay J.B. Prevalence of co-infections with respiratory viruses in individuals investigated for SARS-CoV-2 in Ontario. Canada. Viruses. 2021;13:130. doi: 10.3390/v13010130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010130</ArticleId><ArticleId IdType="pmc">PMC7831481</ArticleId><ArticleId IdType="pubmed">33477649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: A systematic review and meta-analysis. J. Infect. 2020;81:266–275. doi: 10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumbein H., Kümmel L.S., Fragkou P.C., Thölken C., Hünerbein B.L., Reiter R., Papathanasiou K.A., Renz H., Skevaki C. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis. Rev. Med. Virol. 2023;33:e2365. doi: 10.1002/rmv.2365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2365</ArticleId><ArticleId IdType="pmc">PMC9347814</ArticleId><ArticleId IdType="pubmed">35686619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengoechea J.A., Bamford C.G. SARS-CoV-2. bacterial co-infections. and AMR: The deadly trio in COVID-19? EMBO Mol. Med. 2020;12:e12560. doi: 10.15252/emmm.202012560.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012560</ArticleId><ArticleId IdType="pmc">PMC7283846</ArticleId><ArticleId IdType="pubmed">32453917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque M.N., Chaudhury A., Akanda M.A.M., Hossain M.A., Islam M.T. Genomic diversity and evolution. diagnosis. prevention. and therapeutics of the pandemic COVID-19 disease. PeerJ. 2020;8:e9689. doi: 10.7717/peerj.9689.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9689</ArticleId><ArticleId IdType="pmc">PMC7510477</ArticleId><ArticleId IdType="pubmed">33005486</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.-P.R., Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020;26:1622–1629. doi: 10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatiwada S., Subedi A. Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications. Hum. Microbiome J. 2020;17:100073. doi: 10.1016/j.humic.2020.100073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humic.2020.100073</ArticleId><ArticleId IdType="pmc">PMC7405772</ArticleId><ArticleId IdType="pubmed">32835135</ArticleId></ArticleIdList></Reference><Reference><Citation>Peddu V., Shean R.C., Xie H., Shrestha L., Perchetti G.A., Minot S.S., Roychoudhury P., Huang M., Nalla A., Reddy S.B., et al. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization. Clin. Chem. 2020;66:966–972. doi: 10.1093/clinchem/hvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa106</ArticleId><ArticleId IdType="pmc">PMC7239240</ArticleId><ArticleId IdType="pubmed">32379863</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H., Kobayashi T., Miyama T., Suzuki A., Jung S.M., Hayashi K., Kinoshita R., Yang Y., Yuan B., Akhmetzhanov A.R., et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) Int. J. Infect. Dis. 2020;94:154–155. doi: 10.1016/j.ijid.2020.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.020</ArticleId><ArticleId IdType="pmc">PMC7270890</ArticleId><ArticleId IdType="pubmed">32179137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., Sun X., Ye J., Ding L., Liu M., Yang Z., Lu X., Zhang Y., Ma L., Gu W., et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell. Mol. Immunol. 2020;17:621–630. doi: 10.1038/s41423-020-0458-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0458-z</ArticleId><ArticleId IdType="pmc">PMC7227451</ArticleId><ArticleId IdType="pubmed">32415260</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifonova I., Christova I., Madzharova I., Angelova S., Voleva S., Yordanova R., Tcherveniakova T., Krumova S., Korsun N. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection. Front Public Health. 2022;10:959319. doi: 10.3389/fpubh.2022.959319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.959319</ArticleId><ArticleId IdType="pmc">PMC9479447</ArticleId><ArticleId IdType="pubmed">36117597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinghausen C., Gulraiz F., Heinzmann A.C., Dentener M.A., Savelkoul P.H., Wouters E.F., Rohde G.G., Stassen F.R. Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. Respir. Res. 2016;17:68. doi: 10.1186/s12931-016-0382-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-016-0382-z</ArticleId><ArticleId IdType="pmc">PMC4891894</ArticleId><ArticleId IdType="pubmed">27259950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalbiaktluangi C., Yadav M.K., Singh P.K., Singh A., Iyer M., Vellingiri B., Zomuansangi R., Zothanpuia, Ram H. A cooperativity between virus and bacteria during respiratory infections. Front. Microbiol. 2023;14:1279159. doi: 10.3389/fmicb.2023.1279159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1279159</ArticleId><ArticleId IdType="pmc">PMC10720647</ArticleId><ArticleId IdType="pubmed">38098657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoneim H.E., Thomas G., and McCullers J.A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J. Immunol. 2013;191:1250–1259. doi: 10.4049/jimmunol.1300014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300014</ArticleId><ArticleId IdType="pmc">PMC4907362</ArticleId><ArticleId IdType="pubmed">23804714</ArticleId></ArticleIdList></Reference><Reference><Citation>Short J.L., Toffel M.W., Hugill A.R. Monitoring global supply chains. Strateg. Manag. J. 2016;37:1878–1897. doi: 10.1002/smj.2417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smj.2417</ArticleId></ArticleIdList></Reference><Reference><Citation>Avadhanula V., Rodriguez C.A., DeVincenzo J.P., Wang Y., Webby R.J., Ulett G.C., Adderson E.E. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species-and cell type-dependent manner. J. Virol. 2006;80:1629–1636. doi: 10.1128/JVI.80.4.1629-1636.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.4.1629-1636.2006</ArticleId><ArticleId IdType="pmc">PMC1367158</ArticleId><ArticleId IdType="pubmed">16439519</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakis A., Móré D., Erdmann S., Kintzelé L., Fischer R.M., Vogel M.N., Mangold D.L., von Stackelberg O., Schnitzler P., Zimmermann S., et al. COVID-19 pneumonia and its lookalikes: How radiologists perform in differentiating atypical pneumonias. Eur. J. Radiol. 2021;144:110002. doi: 10.1016/j.ejrad.2021.110002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2021.110002</ArticleId><ArticleId IdType="pmc">PMC8524806</ArticleId><ArticleId IdType="pubmed">34700092</ArticleId></ArticleIdList></Reference><Reference><Citation>Chibabhai V., Duse A.G., Perovic O., Richards G.A. Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes? SAMJ S. Afr. Med. J. 2020;110:1–2. doi: 10.7196/SAMJ.2020.v110i7.14917.</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v110i7.14917</ArticleId><ArticleId IdType="pubmed">32880323</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman C., Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia. 2021;13:5. doi: 10.1186/s41479-021-00083-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41479-021-00083-w</ArticleId><ArticleId IdType="pmc">PMC8068564</ArticleId><ArticleId IdType="pubmed">33894790</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayyosi M.G., Khuri-Bulos N.A., Halasa N.B., Faouri S., Shehabi A.A. Rare occurrence of Bordetella pertussis among Jordanian children younger than two years old with respiratory tract infections. J. Pediatr. Infect. Dis. 2015;10:053–056. doi: 10.1055/s-0035-1567874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1567874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodani M., Yang G., Conklin L.M., Travis T.C., Whitney C.G., Anderson L.J., Schrag S.J., Taylor T.H., Jr., Beall B.W., Breiman R.F., et al. Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J. Clin. Microbiol. 2011;49:2175–2182. doi: 10.1128/JCM.02270-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02270-10</ArticleId><ArticleId IdType="pmc">PMC3122721</ArticleId><ArticleId IdType="pubmed">21471348</ArticleId></ArticleIdList></Reference><Reference><Citation>Dare R.K., Fry A.M., Chittaganpitch M., Sawanpanyalert P., Olsen S.J., Erdman D.D. Human coronavirus infections in rural Thailand: A comprehensive study using real-time reverse-transcription polymerase chain reaction assays. J. Infect. Dis. 2007;196:1321–1328. doi: 10.1086/521308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521308</ArticleId><ArticleId IdType="pmc">PMC7109921</ArticleId><ArticleId IdType="pubmed">17922396</ArticleId></ArticleIdList></Reference><Reference><Citation>ARDS Definition Task Force. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307:2526–2533. doi: 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara N., Campobasso C.P., Cocozza S., Conti V., Davinelli S., Costantino M., Cannavo A., Rengo G., Filippelli A., Corbi G. Relationship between COVID-19 mortality, hospital beds, and primary care by Italian regions: A lesson for the future. J. Clin. Med. 2022;11:4196. doi: 10.3390/jcm11144196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11144196</ArticleId><ArticleId IdType="pmc">PMC9315865</ArticleId><ArticleId IdType="pubmed">35887959</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed N.K., Al-Khawaja S., Alsalman J., Almusawi S., Albalooshi N.A., Al-Biltagi M. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World J. Virol. 2021;10:168. doi: 10.5501/wjv.v10.i4.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v10.i4.168</ArticleId><ArticleId IdType="pmc">PMC8316874</ArticleId><ArticleId IdType="pubmed">34367932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu C., Singh S., Pathak A., Singh S., Patel S.S., Ghoshal U., Garg A. Bacterial coinfections in COVID: Prevalence. antibiotic sensitivity patterns and clinical outcomes from a tertiary institute of Northern India. J. Fam. Med. Prim. Care. 2022;11:4473–4478. doi: 10.4103/jfmpc.jfmpc_41_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_41_22</ArticleId><ArticleId IdType="pmc">PMC9638600</ArticleId><ArticleId IdType="pubmed">36353034</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X., Li K., Lei Z., Luo J., Wang Q., Wei S. Prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza: A systematic review and meta-analysis. Int. J. Infect. Dis. 2023;136:29–36. doi: 10.1016/j.ijid.2023.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.08.021</ArticleId><ArticleId IdType="pubmed">37648094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H., Zhou L., Lv J., Yang S., Chen G., Liu X., Han C., Tan X., Qian S., Wu Z., et al. Bacterial coinfections contribute to severe COVID-19 in winter. Cell Res. 2023;33:562–564. doi: 10.1038/s41422-023-00821-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-023-00821-3</ArticleId><ArticleId IdType="pmc">PMC10204009</ArticleId><ArticleId IdType="pubmed">37221267</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhumaid S., Al Mutair A., Al Alawi Z., Alshawi A.M., Alomran S.A., Almuhanna M.S., Almuslim A.A., Bu Shafia A.H., Alotaibi A.M., Ahmed G.Y., et al. Coinfections with bacteria. fungi. and respiratory viruses in patients with SARS-CoV-2: A systematic review and meta-analysis. Pathogens. 2021;10:809. doi: 10.3390/pathogens10070809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10070809</ArticleId><ArticleId IdType="pmc">PMC8308492</ArticleId><ArticleId IdType="pubmed">34202114</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh V., Upadhyay P., Reddy J., Granger J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int. J. Infect. Dis. 2021;105:617–620. doi: 10.1016/j.ijid.2021.02.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.087</ArticleId><ArticleId IdType="pmc">PMC7905386</ArticleId><ArticleId IdType="pubmed">33640570</ArticleId></ArticleIdList></Reference><Reference><Citation>Contou D., Claudinon A., Pajot O., Micaëlo M., Longuet Flandre P., Dubert M., Cally R., Logre E., Fraissé M., Mentec H. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann. Intensive Care. 2020;10:119. doi: 10.1186/s13613-020-00736-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00736-x</ArticleId><ArticleId IdType="pmc">PMC7475952</ArticleId><ArticleId IdType="pubmed">32894364</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkakoty B., Bali N.K. Haemophilus influenzae and SARS-CoV-2: Is there a role for investigation? Indian J. Med. Microbiol. 2021;39:240–244. doi: 10.1016/j.ijmmb.2021.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmmb.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC7997678</ArticleId><ArticleId IdType="pubmed">33781659</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies-Bolorunduro O.F., Fowora M.A., Amoo O.S., Adeniji E., Osuolale K.A., Oladele O., Onuigbo T.I., Obi J.C., Oraegbu J., Ogundepo O., et al. Evaluation of respiratory tract bacterial co-infections in SARS-CoV-2 patients with mild or asymptomatic infection in Lagos. Nigeria. Bull. Natl. Res. Cent. 2022;46:115. doi: 10.1186/s42269-022-00811-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42269-022-00811-2</ArticleId><ArticleId IdType="pmc">PMC9022018</ArticleId><ArticleId IdType="pubmed">35469122</ArticleId></ArticleIdList></Reference><Reference><Citation>Swets M.C., Russell C.D., Harrison E.M., Docherty A.B., Lone N., Girvan M., Hardwick H.E., ISARIC4C Investigators. Visser L.G., Openshaw P.J.M., et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus. or adenoviruses. Lancet. 2022;399:1463–1464. doi: 10.1016/S0140-6736(22)00383-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00383-X</ArticleId><ArticleId IdType="pmc">PMC8956294</ArticleId><ArticleId IdType="pubmed">35344735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085–2086. doi: 10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatore P.P., Dawson P., Wadhwa A., Rabold E.M., Buono S., Dietrich E.A., Reses H.E., Vuong J., Pawloski L., Dasu T., et al. Epidemiological correlates of polymerase chain reaction cycle threshold values in the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin. Infect. Dis. 2021;72:e761–e767. doi: 10.1093/cid/ciaa1469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1469</ArticleId><ArticleId IdType="pmc">PMC7543310</ArticleId><ArticleId IdType="pubmed">32986120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak M.D., Sordillo E.M., Gitman M.R., Mondolfi A.E.P. Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus? J. Med. Virol. 2020;92:1699. doi: 10.1002/jmv.25953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25953</ArticleId><ArticleId IdType="pmc">PMC7267652</ArticleId><ArticleId IdType="pubmed">32352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade S.F., Diouara A.A.M., Ngom B., Thiam F., Dia N. SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology. Microorganisms. 2024;12:540. doi: 10.3390/microorganisms12030540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms12030540</ArticleId><ArticleId IdType="pmc">PMC10974907</ArticleId><ArticleId IdType="pubmed">38543591</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifonova I., Korsun N., Madzharova I., Alexiev I., Ivanov I., Levterova V., Grigorova L., Stoikov I., Donchev D., Christova I. Epidemiological and Genetic Characteristics of Respiratory Viral Coinfections with Different Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viruses. 2024;16:958. doi: 10.3390/v16060958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16060958</ArticleId><ArticleId IdType="pmc">PMC11209099</ArticleId><ArticleId IdType="pubmed">38932250</ArticleId></ArticleIdList></Reference><Reference><Citation>Babawale P.I., Guerrero-Plata A. Respiratory Viral Coinfections: Insights into Epidemiology, Immune Response. Pathology. and Clinical Outcomes. Pathogens. 2024;13:316. doi: 10.3390/pathogens13040316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens13040316</ArticleId><ArticleId IdType="pmc">PMC11053695</ArticleId><ArticleId IdType="pubmed">38668271</ArticleId></ArticleIdList></Reference><Reference><Citation>AlBahrani S., AlZahrani S.J., Al-Maqati T.N., Almehbash A., Alshammari A., Bujlai R., Taweel S.B., Almasabi F., AlAmari A., Al-Tawfiq J.A. Dynamic Patterns and Predominance of Respiratory Pathogens Post-COVID-19: Insights from a Two-Year Analysis. J. Epidemiol. Glob. Health. 2024;14:311–318. doi: 10.1007/s44197-024-00213-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44197-024-00213-9</ArticleId><ArticleId IdType="pmc">PMC11176149</ArticleId><ArticleId IdType="pubmed">38589755</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattemore P.K., Jennings L.C. Pediatric Respiratory Medicine. 2nd ed. Mosby; Maryland Heights, MO, USA: 2008. Chapter 31—Epidemiology of respiratory infections; pp. 435–452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-032304048-8.50035-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenstein S., Hedrich C.M. SARS-CoV-2 infections in children and young people. Clin. Immunol. 2020;220:108588. doi: 10.1016/j.clim.2020.108588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108588</ArticleId><ArticleId IdType="pmc">PMC7474910</ArticleId><ArticleId IdType="pubmed">32905851</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang H., Wang F., Lu X., Du H., Xu J., Han F., Zhang L., Zhang M. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children: A retrospective study. Medicine. 2021;100:e24315. doi: 10.1097/MD.0000000000024315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024315</ArticleId><ArticleId IdType="pmc">PMC7982148</ArticleId><ArticleId IdType="pubmed">33725930</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaaslan A., Çetin C., Akın Y., Tekol S.D., Söbü E., Demirhan R. Coinfection in SARS-CoV-2 infected children patients. J. Infect. Dev. Ctries. 2021;15:761–765. doi: 10.3855/jidc.14314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.14314</ArticleId><ArticleId IdType="pubmed">34242183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Rivera B., Saldaña-Ahuactzi Z., Parra-Ortega I., Flores-Alanis A., Carbajal-Franco E., Cruz-Rangel A., Galaviz-Hernández S., Romero-Navarro B., de la Rosa-Zamboni D., Salazar-García M., et al. Frequency of respiratory virus-associated infection among children and adolescents from a tertiary-care hospital in Mexico City. Sci. Rep. 2023;13:19763. doi: 10.1038/s41598-023-47035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47035-6</ArticleId><ArticleId IdType="pmc">PMC10643542</ArticleId><ArticleId IdType="pubmed">37957308</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Koofy N.M., El-Shabrawi M.H., Abd El-alim B.A., Zein M.M., Badawi N.E. Patterns of respiratory tract infections in children under 5 years of age in a low–middle-income country. J. Egypt. Public Health Assoc. 2022;97:22. doi: 10.1186/s42506-022-00118-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42506-022-00118-0</ArticleId><ArticleId IdType="pmc">PMC9637678</ArticleId><ArticleId IdType="pubmed">36336730</ArticleId></ArticleIdList></Reference><Reference><Citation>Solito C., Hernández-García M., Casamayor N.A., Ortiz A.P., Pino R., Alsina L., de Sevilla M.F. COVID-19 admissions: Trying to define the real impact of infection in hospitalized patients. An. Pediatría. 2024;100:342–351. doi: 10.1016/j.anpedi.2024.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anpedi.2024.02.016</ArticleId><ArticleId IdType="pubmed">38580601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchar E., Załęski A., Wronowski M., Krankowska D., Podsiadły E., Brodaczewska K., Lewicka A., Lewicki S., Kieda C., Horban A., et al. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:541–547. doi: 10.1007/s10096-020-04038-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04038-9</ArticleId><ArticleId IdType="pmc">PMC7520378</ArticleId><ArticleId IdType="pubmed">32986153</ArticleId></ArticleIdList></Reference><Reference><Citation>Latouche M., Ouafi M., Engelmann I., Becquart A., Alidjinou E.K., Mitha A., Dubos F. Frequency and burden of disease for SARS-CoV-2 and other viral respiratory tract infections in children under the age of 2 months. Pediatr. Pulmonol. 2024;59:101–110. doi: 10.1002/ppul.26718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26718</ArticleId><ArticleId IdType="pubmed">37795812</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan Y.Y., Yin C.H., Yao Y.M. Update advances on C-reactive protein in COVID-19 and other viral infections. Front. Immunol. 2021;12:720363. doi: 10.3389/fimmu.2021.720363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720363</ArticleId><ArticleId IdType="pmc">PMC8382792</ArticleId><ArticleId IdType="pubmed">34447386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol. 2020;92:2409. doi: 10.1002/jmv.26097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26097</ArticleId><ArticleId IdType="pmc">PMC7301027</ArticleId><ArticleId IdType="pubmed">32516845</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor C.A. COVID-19–Associated Hospitalizations among US Adults Aged ≥ 65 Years—COVID-NET. 13 States, January–August 2023. MMWR. Morb. Mortal. Wkly. Rep. 2023;72:1089–1094. doi: 10.15585/mmwr.mm7240a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7240a3</ArticleId><ArticleId IdType="pmc">PMC10564325</ArticleId><ArticleId IdType="pubmed">37796744</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaida S., Paul R.E., Matsuno S. Viral transmissibility of SARS-CoV-2 accelerates in the winter. similarly to influenza epidemics. Am. J. Infect. Control. 2022;50:1070–1076. doi: 10.1016/j.ajic.2022.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2022.05.009</ArticleId><ArticleId IdType="pmc">PMC9121648</ArticleId><ArticleId IdType="pubmed">35605752</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei-Tavabe N., Kheiri S., Mousavi M.S., Mohammadian-Hafshejani A. The Effect of Monovalent Influenza Vaccine on the Risk of Hospitalization and All-Cause Mortality According to the Results of Randomized Clinical Trials: A Systematic Review and Meta-Analysis. Iran. J. Public Health. 2023;52:924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10362208</ArticleId><ArticleId IdType="pubmed">37484729</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M.G., Stenehjem E., Grannis S., Ball S.W., Naleway A.L., Ong T.C., DeSilva M.B., Natarajan N., Bozio C.H., Lewis N., et al. Effectiveness of COVID-19 vaccines in ambulatory and inpatient care settings. N. Engl. J. Med. 2021;385:1355–1371. doi: 10.1056/NEJMoa2110362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110362</ArticleId><ArticleId IdType="pmc">PMC8451184</ArticleId><ArticleId IdType="pubmed">34496194</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco-Paredes C. Transmissibility of SARS-CoV-2 among fully vaccinated individuals. Lancet. Infect. Dis. 2022;22:16. doi: 10.1016/S1473-3099(21)00768-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00768-4</ArticleId><ArticleId IdType="pmc">PMC8694744</ArticleId><ArticleId IdType="pubmed">34953540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi-Haddad-Zavareh M., Bayani M., Shokri M., Ebrahimpour S., Babazadeh A., Mehraeen R., Moudi E., Rostami A., Barary M., Hosseini A., et al. C-reactive protein as a prognostic indicator in COVID-19 patients. Interdiscip. Perspect. Infect. Dis. 2021;2021:5557582. doi: 10.1155/2021/5557582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5557582</ArticleId><ArticleId IdType="pmc">PMC8083820</ArticleId><ArticleId IdType="pubmed">33968148</ArticleId></ArticleIdList></Reference><Reference><Citation>Mphekgwana P.M., Sono-Setati M.E., Maluleke A.F., Matlala S.F. Low Oxygen Saturation of COVID-19 in Patient Case Fatalities. Limpopo Province. South Africa. J. Respir. 2022;2:77–86. doi: 10.3390/jor2020006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jor2020006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Zhou H.Y., Zheng H., Wu A. Towards Understanding and Identification of Human Viral Co-Infections. Viruses. 2024;16:673. doi: 10.3390/v16050673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16050673</ArticleId><ArticleId IdType="pmc">PMC11126107</ArticleId><ArticleId IdType="pubmed">38793555</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanidis K., Konstantelou E., Yusuf G.T., Oikonomou A., Tavernaraki K., Karakitsos D., Loukides S., Vlahos I. Radiological. epidemiological and clinical patterns of pulmonary viral infections. Eur. J. Radiol. 2021;136:109548. doi: 10.1016/j.ejrad.2021.109548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2021.109548</ArticleId><ArticleId IdType="pmc">PMC7808729</ArticleId><ArticleId IdType="pubmed">33485125</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>